Approved work: AI models in drug discovery: How AI models used to design and develop new molecules and treatments are evaluated and regulated in the UK?
AI could increase the rate of scientific progress, including in the discovery of new drugs and treatments. How are these tools validated? What safeguards are needed to manage inaccuracy and bias? How does UK regulation apply to AI-selected drug candidates?